• Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France
  • Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Croatia Hungary Poland Romania
  • Title: Evaluation of 68Ga-PSMA-11 PET/MRI and PET/CT Imaging for Treatment Planning in Patients with Intermediate and High-Risk Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Poland
  • Study of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)

    Not recruiting

    3 1 1
    Investigated Drugs:
    France
  • Study of Nimorazole Treatment Based on Hypoxia Profile in Head and Neck Cancer Patients Receiving Radiotherapy with Cisplatin

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark Norway
  • Study of Desmopressin for Prevention of Bleeding After Kidney Biopsy in Patients with Rare Glomerulonephritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Poland
  • Study of trastuzumab with chemotherapy and immunotherapy combination for first-line treatment in patients with HER2-positive esophageal squamous cell cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark
  • Study of Plitidepsin Treatment for Adults with Post-COVID-19 Condition

    Not recruiting

    2 1 1
    Spain
  • Study of belantamab mafodotin combined with pomalidomide, dexamethasone, and daratumumab in patients with relapsed/refractory multiple myeloma who previously had 1-3 treatments and are lenalidomide resistant

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Greece
  • Study of HPV vaccine to prevent recurrence of External Genital Warts in previously cured patients: Comparing Human Papillomavirus vaccine versus placebo

    Not recruiting

    3 1 1
    Investigated Diseases:
    France

powered by